These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1053861)

  • 1. The hemophiliac's demand on blood resources: the magnitude of the problem.
    Stengle JM
    Ann N Y Acad Sci; 1975 Jan; 240():155-61. PubMed ID: 1053861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemophilia as a medical and social problem].
    Nosotti NM
    Minerva Med; 1972 Dec; 63(86):4677-9. PubMed ID: 4642650
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum transfusion in hemophiliacs.
    Kimura A
    Tohoku J Exp Med; 1973 Oct; 111(2):125-36. PubMed ID: 4784393
    [No Abstract]   [Full Text] [Related]  

  • 4. Parana Hemophiliac's Home: Curitiba-Parana-Brazil.
    Sprengel W
    Scand J Haematol Suppl; 1984; 40():556. PubMed ID: 6591408
    [No Abstract]   [Full Text] [Related]  

  • 5. [In-vivo control of blood coagulation fractions].
    Richter K; Rex JO; Stinner G; Fünfhausen G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):344-8. PubMed ID: 4195280
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in hemophilia. Part III. Discussion paper: The Red Cross program.
    Greenwalt TJ
    Ann N Y Acad Sci; 1975 Jan; 240():208-12. PubMed ID: 1053865
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemophilia: the blood bank's concern?].
    Smit Sibinga CT
    Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1359-62. PubMed ID: 692762
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentrated antihemophilic factor (AHF) from outdated blood.
    Weaver RA; Gabriel DA; Langdell RD
    Transfusion; 1967; 7(3):168-73. PubMed ID: 6025692
    [No Abstract]   [Full Text] [Related]  

  • 9. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in hemophilia. Part III. Discussion paper: Other points on the problem of blood resources.
    Surgenor DM
    Ann N Y Acad Sci; 1975 Jan; 240():213-4. PubMed ID: 1053866
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 12. Assay of clotting factors in outdated blood bank plasma and its potenial use for therapy in hemophilia and other hemorrhagic dyscrasias.
    Rosenthal RL; Sloan E
    Transfusion; 1966; 6(4):289-92. PubMed ID: 5965694
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of factor VIII and IX inhibitors after first exposure to heat-treated concentrates.
    Hasegawa DK; Edson JR
    Lancet; 1987 Feb; 1(8530):449. PubMed ID: 2880242
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Blood fractions for haemophilia.
    Aledort LM
    Lancet; 1974 Dec; 2(7894):1452. PubMed ID: 4140363
    [No Abstract]   [Full Text] [Related]  

  • 15. [Circulating anticoagulants during hemophilia].
    Josso F; Cosson A; Gazengel C; Allain JP
    Rev Fr Transfus; 1972 Dec; 15(4):281-98. PubMed ID: 4659598
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemophilia treatment: its relationship to blood products.
    Aledort LM; Goodnight SH
    Prog Hematol; 1981; 12():125-41. PubMed ID: 6803297
    [No Abstract]   [Full Text] [Related]  

  • 18. [Technic of obtaining the antihemophilic factors VIII and IX and their clinical application].
    Triginer J; Vila M; Vicente Arangüena P
    Sangre (Barc); 1979; 24(5-C):937-41. PubMed ID: 121169
    [No Abstract]   [Full Text] [Related]  

  • 19. [Substitution therapy with factor 8 and factor IX preparations].
    Landbeck G
    Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
    [No Abstract]   [Full Text] [Related]  

  • 20. Designated discussant.
    Djerassi I
    Vox Sang; 1967 Jul; 13(1):126-8. PubMed ID: 6035809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.